TRACON Pharmaceuticals, Inc(NASDAQ:TCON) 
TRACON Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and age-related macular degeneration and fibrotic diseases in the United States. Its lead clinical stage product include envafolimab (KN035), an inves...
Website: http://www.traconpharma.com
Founded: 2004
Full Time Employees: 19
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-06-05
P
O 1.30
H 1.30
L 1.20
C 1.22
V 77,850
10EMA 1.22
20EMA 1.22
60EMA 1.22
120EMA 1.22
250EMA 1.22